Cas9 Antibodies

Santa Cruz Biotechnology offers a broad range of Cas9 monoclonal antibodies for advanced research in gene editing and CRISPR technology. Cas9 Antibodies are available for various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cas9 plays a pivotal role in the CRISPR-Cas9 system, enabling precise genome editing by creating double-strand breaks in DNA at targeted locations. The ability to program Cas9 to target specific genetic sequences makes it an essential component in genetic research, therapeutic development, and biotechnology applications. Understanding the function and regulation of Cas9 is vital for advancing gene editing technologies and their potential applications in medicine and agriculture. Researchers worldwide utilize Cas9 monoclonal antibodies to explore fundamental questions about gene editing mechanisms and cellular responses to DNA modifications. The development of enhanced gene editing tools continues to drive innovation in therapeutic strategies and agricultural improvements. Santa Cruz Biotechnology monoclonal antibodies for Cas9 support researchers in advancing scientific understanding and developing novel applications in genome engineering.